Hawaii Dermatology Seminar Day 1
Hawaii Dermatology Seminar Day 1
February 18, 2024
—by Colleen Hutchinson
Hello and welcome to the conclusion of Day 1 of the 46th Annual Hawaii Dermatology Seminar!
With faculty who specialize in everything from acne, atopic dermatitis (AD), and psoriasis to skin cancers, surgical pearls, and nonsurgical facial rejuvenation, Hawaii Derm brings you the latest dermatological advancements—with presentations that define the latest proven breakthrough treatments for your hardest patient cases. A robust and comprehensive agenda targets all new developments in medical and aesthetic medicine and the treatment of skin diseases, this 5-day event covers all of your CME needs in one meeting.
“The Hawaii Derm agenda is quite comprehensive! It covers acne and rosacea, skin cancers, psoriasis and atopic dermatitis, pediatric dermatology and aesthetics, and so much more. I am always motivated and excited to hear about new drugs and what is coming down the pipeline to help my patients.”—Julie Harper, MD
“The faculty assembled for Hawaii Derm is superb, representing some of the most famous names in medical and pediatric dermatology—such as Jeff Callen and Amy Paller—leaders who write our standard textbooks and advance the field, while also being expert clinicians and fabulous speakers,” shared Dr. Lawrence Eichenfield, who co-chairs Hawaii Derm.”
He highlighted some of Day 1’s talks he most enjoyed: “Great sessions on acne and rosacea, with the second half of the day devoted to atopic dermatitis, and I was particularly impressed with sessions on AD that included updates on allergic contact dermatitis (from Dr. JiaDe Yu), allergy and am looking forward to Day 2 talks—like urticaria (from Dr. Bob Geng) and presentations on new topical and systemic agents to treat AD!”
“One aspect of my talks that is critical is on JAK inhibitors—they are such an important item in our treatment toolbox for AD patients, shared Dr. Yu. “Novel data continues to be released highlighting their safety and efficacy, so in Session 3 today I shared updated safety data on the systemic JAK inhibitors.”
Keeping current on new treatments is critical, and Hawaii Derm keeps you current. Dr. Yu explained, “The field of atopic dermatitis is so rapidly changing. Kwatra’s talks on what’s coming down the pipeline in AD are greatly helpful so that I know what to offer patients who fail currently available treatments.”
Presenter Andrew Alexis, MD, mentioned one of the most anticipated AD sessions: “I especially appreciated All You Need to Know About Atopic Dermatitis and Then Some—the two-part session led by renowned expert, Melinda Gooderham, with an amazing lineup of speakers covering the latest updates and best practices for treating our patients with AD!”
So what else was not to be missed on Day 1 of Hawaii Derm?
- Updates on Topical Agents in the AD Toolbox—Tina Bhutani, MD
- Biologics for Atopic Dermatitis: What’s New—Melinda J. Gooderham, MD
- JAK Inhibitors for Atopic Dermatitis: What You Need to Know Now—JiaDe Yu, MD
- Looking Ahead at the Atopic Dermatitis Pipeline—Melinda J. Gooderham, MD
- Connective Tissue Diseases in Dermatology—Jeffrey P. Callen, MD
- What’s New in Acne—Andrew F. Alexis, MD
- Approaches to Allergy in Atopic Dermatitis—Bob Geng, MD
Today Session 3 also showcased Drs. Eichenfield and Sean Kwatra presenting, Is Your Patient a Candidate for Systemic Treatment? “We used cases to discuss the practical aspects of deciding when it’s time to escalate treatment, especially in the challenging situation of very young patients,” shared Dr. Eichenfield. “While a pearl there is “It’s always patient and family by patient and family,” we illustrated standard approaches of assessing both disease severity as well as when the patient and family is “ready” to make the move.
Julie Harper, MD, shared, “A common question I get from audiences over the years is: How young is too young for isotretinoin? I am happy to have had the opportunity to share some really interesting information and pearls on this topic.”
“We also discussed treating acne during pregnancy and lactation,” Dr. Harper stated. “I made the case for treating rosacea with a combination approach instead of trying to always do a ‘one drug wonder’, and I addressed ocular rosacea management and describe a relative newcomer—neurogenic rosacea.”
“The difficult case discussions and the talks on hidradenitis suppurativa and pediatric collagen vascular diseases continue to be invaluable,” shared Dr. Jeffrey Callen. “In my presentation, we talked about evaluation of dermatomyositis for potential malignancy, treatment of cutaneous lupus erythematosus and dermatomyositis, and the risks associated with therapies for psoriasis.”
Looking over the agenda, presenter Dr. Julie Harper states:
“I love the case-based discussions and really enjoy the opportunity to hear experts answering challenging questions from the audience. So often they are questions that we all have when treating patients in our clinical practices.”
Attending Hawaii Derm enables you to return to work with the most current treatment armamentarium to date, and to manage the most challenging and difficult-to-treat patients in their clinics, all learned within a few short days.
“At Hawaii Derm, each day you hear short talks with a focus on difficult clinical problems and new methods of evaluation and management,” states Dr. Callen. It’s a lot packed into each session, with every minute used wisely by presenters to cover compelling, critical information for practicing dermatologists. Join us to learn more about how to better care for your patients. Hawaii Derm also has interactive exhibitions, live-patient injection sessions, and workshops. You don't want to miss out!
—by Colleen Hutchinson
Photos of the Day
Attendees enjoying our Hawaii Derm photo corner. Follow #HawaiiDerm24 for more attendee photos.
Attendees and their families check-in early during early registration on Saturday afternoon.
Conference Co-Chair Dr. Lawrence F. Eichenfield kicked off the conference with an enthusiastic welcome.
Pigmentary Disorders Exchange Symposium
Join us at the 2nd Annual Pigmentary Disorders Exchange Symposium taking place June 7-8, 2024, at the Loews Chicago Hotel in Chicago, IL. The two-day CME/CE event will take a deep dive into the treatment of pigmentary disorders and explore a range of topics including:
- The effects of pigmentary disorders on patients' quality of life.
- The need for paradigm shifts in how we approach these individuals.
- The pathogenesis, nuances in clinical presentation, and full range of therapeutic options, including topical approaches, oral interventions, and procedural modalities, for the full spectrum of diseases from hyperpigmentation to hypopigmentation.
Unlike other conferences that only cover the basics of pigmentary disorders, we will go the extra mile to arm each clinician with the right tools to improve treatment outcomes, avoid complications, and mitigate the impact of these conditions on patients’ quality of life.
Dermatology Resource Section
Dermatology News Article: A glimpse at devices designed to tackle cellulite
Cutis Commentary: Treatments for Hidradenitis Suppurativa Comorbidities Help With Pain Management
NEJM Image of the Week: Pyemotes ventricosus Dermatitis
Dermatology News Article: Polypodium leucotomos found to reverse AK skin damage